logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
R

Rodrigo Sánchez-Bayona

medical oncology
H指数:19
被引数:1,189

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Latin American consensus on the medical oncologic management of early-stage HR+/HER2-breast cancer: Addressing regional disparities in Spanish-speaking countries

拉丁美洲关于早期HR+/HER2-乳腺癌肿瘤内科治疗管理的共识：探讨西班牙语国家的区域性差异

Breast
IF7.9
2026-07-010
PRE
Landaverde, Denis U.; Petracci, Fernando; de Oro, Angela Grano; Garzon, Maria A. Bravo; Estevez, Martha; Arce-Salinas, Claudia; Gonzalez, Ileana; Veliz, Ignacio; Amador, Jose Luis; Castillo, Omar; Enciso, Virginia; Codas, Leny; Valencia, Fernando; Galvez, Marco; Valentin-Bejarano, John; Sanchez, Sonia; Lemes-Piston, Valeria; Hannois, Damian; Khanna, Priyanka; Miranda, Juan Pablo; Guillen, Gary; Sanchez-Bayona, Rodrigo; Gavila-Gregori, Joaquin; Vidal-Losada, Maria
Analysis of UGT1A1 germline variants in patients with advanced breast cancer treated with trastuzumab-deruxtecan: results from the PROCURE Project

对接受曲妥珠单抗-德鲁替卡治疗晚期乳腺癌患者UGT1A1胚系变异的分析：PROCURE项目结果

ESMO Open
IF8.3
2026-05-110
OAAI
R. Sánchez-Bayona; J. de Nicolás-Hernández; C. Saura; M. Gion; J.M. Cejalvo; E. Llabrés; J. Cortés; A. Falcón; S. Pernas; A. López de Sa; M. Vidal; C. Hinojo; T. Curiel; J. Cruz; V. Martínez; B. Cantos; M.J. Echarri; I. Gallegos; C. Bueno; A.M. Vargas
Real-world second- and third-line progression-free survival after progression on first-line CDK4/6 inhibitors in HR+/HER2- metastatic breast cancer by PAM50 intrinsic subtype: the SOLTI-1801 CDK-PREDICT study

真实世界中HR+/HER2-转移性乳腺癌在接受一线CDK4/6抑制剂治疗后进展后的二线和三线无进展生存情况，按PAM50固有亚型分析：SOLTI-1801 CDK-PREDICT研究

Breast Cancer Research and Treatment
IF3
2026-02-280
OAAI
Pablo Tolosa; Isabel García-Fructuoso; Tomás Pascual; Olga Martínez-Sáez; Juan Miguel Cejalvo; Sonia Servitja; María Fernández Abad; Javier David Benitez Fuentes; Fara Brasó-Maristany; Ester Sanfeliu; Laura Lema; Yolanda Ruano; Lucía Parrilla; Ana María Roncero; María Ángeles Cobos; Irene Díaz; Karla Alicia Centelles López; Rodrigo Sánchez-Bayona; Manuel Alva; Ainhoa Madariaga; Guillermo Villacampa; Fernando Salvador; Agustín Sánchez-Belmonte; Marcos Malumbres; Aleix Prat; Eva Ciruelos
Validation of the HER2DX genomic test in first-line advanced HER2-positive breast cancer treated with trastuzumab, pertuzumab, and taxane

HER2DX基因组检测在一线治疗中，用于接受曲妥珠单抗、帕妥珠单抗和紫杉类药物治疗的HER2阳性晚期乳腺癌的验证

npj Breast Cancer
IF7.6
2026-02-100
OAAI
Marcin Kubeczko; Sandra Cobo; Rodrigo Sanchez-Bayona; Bartłomiej Pyciński; Jesús Soberino; Ewa Chmielik; Esther Sanfeliu; Maria Rey; Francisco Pardo; Angela Aguirre; Oleguer Castillo; Aleksandra Lesniak; Malgorzata Oczko-Wojciechowska; Esther Carcelero; Barbara Adamo; Maria Vidal; Milana Bergamino; Julia Maues; Guillermo Villacampa; Laia Paré; Patricia Villagrasa; Eva Ciruelos; Aleix Prat; Michal Jarzab; Fara Brasó-Maristany
Co-clinical trial targeting ER, FGFR and CDK4/6 in resistant hormone-positive breast cancer with FGFR alterations

靶向ER、FGFR和CDK4/6的协同临床试验，用于具有FGFR变异的耐药性激素阳性乳腺癌

npj Precision Oncology
IF8
2025-11-070
OAAI
Noelia Martinez-Jañez; José Ángel García-Saenz; Sonia Pernas; Begoña Bermejo; Serafín Morales; Juan Guerra; Jorge Silva; Luis Manso; Eva Ciruelos; Pablo Tolosa; Rodrigo Sánchez-Bayona; Manuel Alva; Silvia Calabuig-Fariñas; Sandra Gallach; Laura Muinelo-Romay; Elena Piñeiro-Yáñez; Eduardo Caleiras; Maria J. Bueno; Silvana Mouron; Miguel Quintela-Fandino
Comparative efficacy between real-world and randomized studies of palbociclib+endocrine therapy in HR-positive/HER2-negative metastatic breast cancer: systematic review and meta-analysis

真实世界研究与随机研究之间帕博西利布联合内分泌疗法在激素受体阳性/人表皮生长因子受体2阴性转移性乳腺癌中的比较疗效：系统评价与meta分析

JNCI CANCER SPECTRUM
IF4.1
2025-10-010
OAAI
Schettini, Francesco; Nucera, Sabrina; Di Grazia, Giuseppe; Giudici, Fabiola; Strina, Carla; Milani, Manuela; Tancredi, Richard; Conte, Benedetta; Criscitiello, Carmen; Giuliano, Mario; Lambertini, Matteo; Sanchez-Bayona, Rodrigo; Pascual, Tomas; Arpino, Grazia; Del Mastro, Lucia; Vigneri, Paolo; Cristofanilli, Massimo; Rugo, Hope S.; Gennari, Alessandra; Curigliano, Giuseppe; Generali, Daniele
HER2DX ERBB2 mRNA score in first-line advanced HER2-positive breast cancer treated with chemotherapy, trastuzumab, and pertuzumab

HER2DX ERBB2 mRNA评分：用于接受化疗、曲妥珠单抗和帕妥珠单抗治疗的一线晚期HER2阳性乳腺癌

NPJ BREAST CANCER
IF7.6
2025-04-250
OA
Sanchez-Bayona, Rodrigo; Martinez-Saez, Olga; Romero-Romero, Denys; Segui, Elia; Carcelero, Esther; Tolosa, Pablo; Soberino, Jesus; Alva, Manuel; Pascual, Tomas; Lema, Laura; Garcia-Fructuoso, Isabel; Cobos-Fernandez, Maria Angeles; Rey, Maria; Manso, Luis; Aguirre, Angela; Madariaga, Ainhoa; Sirenko, Valeria; Gonzalez-Deza, Cristina; Blasco, Paula; Mayhua, Astrid; Castillo, Oleguer; Galvan, Patricia; Sanfeliu, Esther; Villacampa, Guillermo; Buckingham, Wesley; Marin-Aguilera, Mercedes; Pare, Laia; Villagrasa, Patricia; Perou, Charles M.; Maues, Julia; Braso-Maristany, Fara; Ciruelos, Eva
Bridging the gap between real-world studies (RWSs) and randomized controlled trials (RCTs) of 1st-line palbociclib plus aromatase inhibitors (P plus AI) in hormone receptor-positive (HR+)/HER2-negative(-) metastatic breast cancer (mBC)

弥合真实世界研究（RWSs）与1线帕博西利联合芳香化酶抑制剂（P plus AI）在激素受体阳性（HR+)/人表皮生长因子受体2阴性(-)转移性乳腺癌（mBC）中的随机对照试验（RCTs）之间的差距

ANNALS OF ONCOLOGY
IF65.4
2024-09-010
PRE
Nucera, S.; Schettini, F.; Giudici, F.; Strina, C.; Milani, M.; Tancredi, R. J.; Conte, B.; Criscitiello, C.; Giuliano, M.; Lambertini, M.; Sanchez Bayona, R.; Pascual, T.; Vigneri, P.; Arpino, G.; Del Mastro, L.; Cristofanilli, M.; Rugo, H. S.; Gennari, A.; Curigliano, G.; Generali, D.
Abemaciclib for treating patients with HR+/HER2-metastatic breast cancer: a real-world study in France, Italy and Spain

Abemaciclib用于治疗HR /HER2-metastatic乳腺癌患者: 法国，意大利和西班牙的一项现实研究

FUTURE ONCOLOGY
IF2.6
2024-08-080
OAAI
Blancas, Isabel; Grosjean, Jessica; Pedersini, Rebecca; Buzzoni, Carlotta; Sleilaty, Ghassan; Molero, Alberto; Tamma, Antonella; Chouaki, Nadia; Atienza, Manuel; Emde, Anna; Siddi, Sara; Bayona, Rodrigo Sanchez; Del Mastro, Lucia; Fakhouri, Walid
Pregnancy After Breast Cancer in Young BRCA Carriers: An International Hospital-Based Cohort Study Editoral Comment
OBSTETRICAL & GYNECOLOGICAL SURVEY
IF3.6
2024-08-010
OA
Lambertini, Matteo; Blondeaux, Eva; Agostinetto, Elisa; Hamy, Anne-Sophie; Kim, Hee Jeong; Di Meglio, Antonio; Molho, Rinat Bernstein; Hilbers, Florentine; Pogoda, Katarzyna; Carrasco, Estela; Punie, Kevin; Bajpai, Jyoti; Ignatiadis, Michail; Moore, Halle C. F.; Phillips, Kelly-Anne; Toss, Angela; Rousset-Jablonski, Christine; Peccatori, Fedro A.; Renaud, Tiphaine; Ferrari, Alberta; Paluch-Shimon, Shani; Fruscio, Robert; Cui, Wanda; Wong, Stephanie M.; Vernieri, Claudio; Ruddy, Kathryn J.; Dieci, Maria Vittoria; Matikas, Alexios; Rozenblit, Mariya; Villarreal-Garza, Cynthia; de Marchis, Laura; del Mastro, Lucia; Puglisi, Fabio; Estevez-Diz, Maria del Pilar; Rodriguez-Wallberg, Kenny A.; Mrinakova, Bela; Meister, Sarah; Livraghi, Luca; Clatot, Florian; Yerushalmi, Rinat; de Angelis, Carmine; Sanchez-Bayona, Rodrigo; Meattini, Icro; Cichowska-Cwalinska, Natalia; Berliere, Martine; Salama, Mahmoud; de Giorgi, Ugo; Sonnenblick, Amir; Chiodi, Camila; Lee, Young-Jin; Maria, Camille; Azim Jr, Hatem A.; Boni, Luca; Partridge, Ann H.
Patritumab deruxtecan in HER2-negative breast cancer: part B results of the window-of-opportunity SOLTI-1805 TOT-HER3 trial and biological determinants of early response
NATURE COMMUNICATIONS
IF15.7
2024-07-111
OAAI
Braso-Maristany, Fara; Ferrero-Cafiero, Juan Manuel; Falato, Claudette; Martinez-Saez, Olga; Cejalvo, Juan Miguel; Margeli, Mireia; Tolosa, Pablo; Salvador-Bofill, Francisco Javier; Cruz, Josefina; Gonzalez-Farre, Blanca; Sanfeliu, Esther; Odena, Andreu; Serra, Violeta; Pardo, Francisco; Luna Barrera, Ana Maria; Arumi, Miriam; Guerra, Juan Antonio; Villacampa, Guillermo; Sanchez-Bayona, Rodrigo; Ciruelos, Eva; Espinosa-Bravo, Martin; Izarzugaza, Yann; Galvan, Patricia; Matito, Judith; Pernas, Sonia; Vidal, Maria; Santhanagopal, Anu; Sellami, Dalila; Esker, Stephen; Fan, Pang-Dian; Suto, Fumitaka; Vivancos, Ana; Pascual, Tomas; Prat, Aleix; Oliveira, Mafalda
Everolimus plus endocrine therapy beyond CDK4/6 inhibitors progression for HR+ /HER2-advanced breast cancer: a real-world evidence cohort

依维莫司联合内分泌治疗超越CDK4/6抑制剂治疗HR /HER2-advanced乳腺癌的进展: 真实世界证据队列

BREAST CANCER RESEARCH AND TREATMENT
IF3
2024-05-048
PRE
Sanchez-Bayona, Rodrigo; de Sa, Alfonso Lopez; Gilarranz, Yolanda Jerez; de Torre, Ana Sanchez; Alva, Manuel; Echavarria, Isabel; Moreno, Fernando; Tolosa, Pablo; Lopez, Blanca Herrero; de Luna, Alicia; Lema, Laura; Casado, Salvador Gamez; Madariaga, Ainhoa; Lopez-Tarruella, Sara; Manso, Luis; Bueno-Muino, Coralia; Garcia-Saenz, Jose A.; Ciruelos, Eva; Martin, Miguel

研究方向

暂未获取到该数据
E
Estefanía Toledo
H 指数:75论文数:434被引数:2.1万
L
Luís Manso
H 指数:39论文数:451被引数:8,425
M
Miguel Ángel Martínez‐González
H 指数:143论文数:1,564被引数:8.6万
P
Pablo Tolosa
H 指数:14论文数:97被引数:673
A
Andrea Romanos-Nanclares
H 指数:18论文数:67被引数:924
E
Eva Ciruelos
H 指数:54论文数:695被引数:1.9万
T
Tomás Pascual
H 指数:35论文数:449被引数:5,566
L
Laura Lema
H 指数:4论文数:34被引数:78
A
Alfredo Gea
H 指数:47论文数:186被引数:1.2万
A
Aleix Prat
H 指数:92论文数:1,351被引数:3.6万